Search Results - "You, Joyce H S"

Refine Results
  1. 1

    Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis by Fekadu, Ginenus, Yao, Jiaqi, You, Joyce H. S

    Published in PloS one (05-08-2022)
    “…Background The treatment success rate of conventional anti-tuberculosis (TB) regimens for extensively drug-resistant TB (XDR-TB) is low, resulting in high…”
    Get full text
    Journal Article
  2. 2

    Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States by Fekadu, Ginenus, Yao, Jiaqi, You, Joyce H. S.

    Published in Scientific reports (01-11-2022)
    “…Tuberculosis infection (TBI) frequently progresses to tuberculosis (TB) disease in people co-infected with human immunodeficiency virus (HIV). We examined the…”
    Get full text
    Journal Article
  3. 3

    Cost-effectiveness analysis of carbetocin for prevention of postpartum hemorrhage in a low-burden high-resource city of China by You, Joyce H S, Leung, Tak-Yeung

    Published in PloS one (15-12-2022)
    “…Postpartum hemorrhage (PPH) is a major cause of maternal morbidity, and oxytocin is the first-line uterotonic agent for PPH prevention. Clinical findings have…”
    Get full text
    Journal Article
  4. 4

    Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis by You, Joyce H. S.

    “…ABSTRACT BACKGROUND The decision as to whether to use more expensive novel oral anticoagulants (NOACs) or invest resources for quality improvement of warfarin…”
    Get full text
    Journal Article
  5. 5

    Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic-A cost-effectiveness analysis by Yao, Jiaqi, Fekadu, Ginenus, Jiang, Xinchan, You, Joyce H S

    Published in PloS one (07-04-2022)
    “…COVID-19 pandemic burdens the healthcare systems, causes healthcare avoidance, and might worsen the outcomes of inflammatory bowel disease (IBD) management. We…”
    Get full text
    Journal Article
  6. 6

    Ultrasound-guided manual vacuum aspiration (USG-MVA) with cervical preparation for early pregnancy loss: A cost-effectiveness analysis by Chung, Jacqueline Pui-Wah, Fekadu, Ginenus, Sahota, Daljit Singh, Leung, Tak-Yeung, You, Joyce H. S

    Published in PloS one (03-11-2023)
    “…Background and aim Approximately one in four women will experience a miscarriage in their lifetime. Ultrasound-guided manual vacuum aspiration (USG-MVA) is an…”
    Get full text
    Journal Article
  7. 7

    Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children by Wong, Carlos, Jiang, Minghuan, You, Joyce H S

    Published in PloS one (22-12-2016)
    “…The influenza vaccine coverage rate of children is low in Hong Kong. Microneedle patches (MNPs) is a technology under development for painless delivery of…”
    Get full text
    Journal Article
  8. 8

    Cost-effectiveness of internet-supported cognitive behavioral therapy for university students with anxiety symptoms: A Markov-model analysis by You, Joyce H S, Luk, Scotty W C, Chow, Dilys Y W, Jiang, Xinchan, Mak, Arthur D P, Mak, Winnie W S

    Published in PloS one (05-05-2022)
    “…High prevalence of anxiety symptoms has been reported globally in the university students. Cognitive behavioral therapy (CBT) is the recognized treatment for…”
    Get full text
    Journal Article
  9. 9

    Comparative Cost-Effectiveness Analysis of Respiratory Syncytial Virus Vaccines for Older Adults in Hong Kong by Wang, Yingcheng, Fekadu, Ginenus, You, Joyce H. S

    Published in Vaccines (Basel) (01-10-2023)
    “…Two respiratory syncytial virus (RSV) vaccines (AREXVY® and ABRYSVO®) were recently approved for older adults in the US. This study aimed to evaluate the…”
    Get full text
    Journal Article
  10. 10

    Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting by You, Joyce H S, Tam, Lok-Pui, Lee, Nelson L S

    Published in PloS one (27-07-2017)
    “…Early initiation of antiviral therapy in elderly patients with influenza is associated with reduced risk of extra clinic visit, hospitalization and death. This…”
    Get full text
    Journal Article
  11. 11

    Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection by Jiang, Minghuan, Leung, Nok-Hang, Ip, Margaret, You, Joyce H S

    Published in PloS one (26-07-2018)
    “…Clostridium difficile infection (CDI) caused by ribotype 002 strain is associated with poor outcomes in Chinese patients. Fecal microbiota transplantation…”
    Get full text
    Journal Article
  12. 12

    EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong - A cost-effectiveness analysis by You, Joyce H S, Cho, William C S, Ming, Wai-Kit, Li, Yu-Chung, Kwan, Chung-Kong, Au, Kwok-Hung, Au, Joseph Siu-Kie

    Published in PloS one (01-03-2021)
    “…Tyrosine kinase inhibitors (TKIs) therapy targets at epidermal growth factor receptor (EGFR) gene mutations in non-small-cell lung cancer (NSCLC). We aimed to…”
    Get full text
    Journal Article
  13. 13

    Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults by You, Joyce H S, Ming, Wai-Kit, Tsang, Owen Tak-Yin, Chan, Paul Kay-Sheung

    Published in PloS one (04-01-2019)
    “…Adjuvanted herpes zoster (HZ) subunit (HZ/su) vaccine is recommended for healthy adults aged ≥50 years, yet vaccine efficacy is expected to wane over time…”
    Get full text
    Journal Article
  14. 14

    CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis by Jiang, Minghuan, You, Joyce H. S.

    Published in Cardiovascular drugs and therapy (01-02-2017)
    “…Purpose This study aimed to examine the cost-effectiveness of CYP2C19 loss-of-function and gain-of-function allele guided (LOF/GOF-guided) antiplatelet therapy…”
    Get full text
    Journal Article
  15. 15

    Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation by You, Joyce H S, Tsui, Kia K N, Wong, Raymond S M, Cheng, Gergory

    Published in PloS one (22-06-2012)
    “…Dabigatran is associated with lower rate of stroke comparing to warfarin when anticoagulation control is sub-optimal. Genotype-guided warfarin dosing and…”
    Get full text
    Journal Article
  16. 16

    Deprescribing of proton pump inhibitors in older patients: A cost-effectiveness analysis by Xie, Mingxi, You, Joyce H S

    Published in PloS one (07-10-2024)
    “…Over-prescribing of proton-pump inhibitors (PPIs) is widely observed in older patients. Clinical findings have showed that deprescribing service significantly…”
    Get full text
    Journal Article
  17. 17

    A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong by You, Joyce H S, Chan, Eva S K, Leung, Maggie Y K, Ip, Margaret, Lee, Nelson L S

    Published in PloS one (29-03-2012)
    “…Seasonal and 2009 H1N1 influenza viruses may cause severe diseases and result in excess hospitalization and mortality in the older and younger adults,…”
    Get full text
    Journal Article
  18. 18

    Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis by Fekadu, Ginenus, Wang, Yingcheng, You, Joyce H S

    Published in PloS one (14-07-2023)
    “…Recent clinical findings reported the reduced mortality associated with treatment guided by sputum-based molecular test with urine-based lipoarabinomannan…”
    Get full text
    Journal Article
  19. 19

    Review of pharmacoeconomic evaluation of genotype-guided antiplatelet therapy by Jiang, Minghuan, You, Joyce H S

    Published in Expert opinion on pharmacotherapy (01-04-2015)
    “…Clopidogrel is an antiplatelet agent widely prescribed for acute coronary syndrome (ACS), and it is activated by the CYP enzyme system to active metabolite…”
    Get more information
    Journal Article
  20. 20

    Proactive therapeutic drug monitoring of adalimumab for pediatric Crohn's disease patients: A cost‐effectiveness analysis by Yao, Jiaqi, Jiang, Xinchan, You, Joyce H S

    Published in Journal of gastroenterology and hepatology (01-09-2021)
    “…Background and Aim Recent clinical findings showed proactive therapeutic drug monitoring (TDM) of adalimumab (ADL) to improve sustained remission rate in…”
    Get full text
    Journal Article